Technically Speakin...
Health Care: Drugs
Biosante Pharmaceuticals Inc. (BPAX: NASDAQ)
$2.22 -0.09 | -3.90%
06/04/12 - 11:29 AM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 1.22 | 0.58 | 0.98 |
| Price to Sales (TTM) | 94.82 | 4.62 | 1.42 |
| Price to Book (MRQ) | 1.23 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 1.23 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | -1.00 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -1.00 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 100.00 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -82.40 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | -29.54 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 55.63 | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 8.10 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 8.20 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.28 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.28 | 0.45 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 89.80 | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | 96.20 | 83.50 | 47.70 |
| EBITD Margin (TTM) | n.a. | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -606.87 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -90.67 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 5.30 | 7.00 |
| Return on Assets (TTM) | -81.80 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | -88.50 | 2.20 | 2.50 |
| Return on Investment (TTM) | -92.00 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | -101.00 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 9,114.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | -826,339.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | n.a. | 5.80 | 7.60 |
| Inventory Turnover (TTM) | n.a. | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.00 | 0.40 | 0.40 |
Portfolios with BPAX
- Portfolio NameUser Type
- UserSaveyn walter
- User2012_03
- Userwayne120
- ContributorBreakout Stocks Of The Week...
- UserDunDon1
- Contributor6 Drug Stocks Unworthy of B...
- Contributor3 Small-Cap Stocks on Insid...
- Contributor13 Biotech Stocks Bought an...
- UserSMITTY
- Contributor10 Most Shorted Stocks in B...
Latest BPAX Headlines from TheStreet
- Biosante Stock Gaps Down On Today's Open (BPAX) 06.01.12 | 09:06 am
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Transocean, Netflix, BioSante Are Market Movers 02.27.12 | 05:02 pm
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- Biosante Stock Falls On Unusually High Volume (BPAX) 02.07.12 | 11:02 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Market Preview: The Year Without a Santa Claus Rally 12.14.11 | 08:12 pm
- Novellus, BioSante: After-Hours Trading 12.14.11 | 07:12 pm
Press Releases for BPAX
- BioSante Pharmaceuticals, Inc. To Present At Jefferies Global Healthcare Conference - Business Wire 06.04.12 | 07:06 am
- BioSante Pharmaceuticals Announces Reverse Stock Split In Order To Maintain NASDAQ Listing - Business Wire 05.31.12 | 08:05 pm
- BioSante Pharmaceuticals Reports First Quarter Financial Results - Business Wire 05.08.12 | 04:05 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - PR Newswire 04.04.12 | 05:04 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.03.12 | 02:04 pm
- BioSante Pharmaceuticals Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of BioSante Pharmaceuticals, Inc. - Business Wire 03.29.12 | 05:03 pm
- BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation - Business Wire 03.20.12 | 07:03 am
- BioSante Pharmaceuticals Reports Financial Results For 2011 And Corporate Highlights - Business Wire 03.13.12 | 05:03 pm
- BioSante Pharmaceuticals, Inc. To Present At Roth Health Care Conference - Business Wire 03.09.12 | 07:03 am
- BioSante’s Prostate Cancer Vaccine Resulted In Stable Disease In Over 50% Of Patients In Newly Published Study - Business Wire 03.05.12 | 07:03 am
Partner Headlines for BPAX
- Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha 03.26.12 | 09:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- What BioSante's Balance Sheet Says About Future R&D - Seeking Alpha 03.01.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Singular Research Drops Coverage on BioSante Pharma After LibGel Results - Benzinga 12.16.11 | 04:12 pm
- Singular Research Reiterates BioSante Pharmaceuticals Buy, Maintains PT - Benzinga 12.13.11 | 01:12 pm
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
